4.60
전일 마감가:
$4.95
열려 있는:
$4.99
하루 거래량:
230.05K
Relative Volume:
0.62
시가총액:
$245.17M
수익:
$17.63M
순이익/손실:
$-57.71M
주가수익비율:
-3.1081
EPS:
-1.48
순현금흐름:
$-60.45M
1주 성능:
-0.65%
1개월 성능:
+4.78%
6개월 성능:
+25.00%
1년 성능:
-9.09%
Scpharmaceuticals Inc Stock (SCPH) Company Profile
명칭
Scpharmaceuticals Inc
전화
617-517-0730
주소
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
SCPH을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
SCPH
Scpharmaceuticals Inc
|
4.60 | 263.83M | 17.63M | -57.71M | -60.45M | -1.48 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-09-07 | 개시 | Craig Hallum | Buy |
2022-12-01 | 개시 | Cowen | Outperform |
2022-10-21 | 재개 | Jefferies | Buy |
2022-10-11 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2022-08-02 | 개시 | Maxim Group | Buy |
2021-09-09 | 개시 | SVB Leerink | Mkt Perform |
2019-10-15 | 개시 | H.C. Wainwright | Buy |
2019-01-30 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
모두보기
Scpharmaceuticals Inc 주식(SCPH)의 최신 뉴스
RSI Crosses Above 30 for scPharmaceuticals Inc. — Reversal in SightBreakout Watch & Scalable Portfolio Growth Ideas - sundaytimes.kr
What makes scPharmaceuticals Inc. stock price move sharply2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
Using R and stats models for scPharmaceuticals Inc. forecastingJuly 2025 Trends & Stepwise Trade Signal Implementation - Newser
Using data tools to time your scPharmaceuticals Inc. exitJuly 2025 Highlights & Real-Time Buy Signal Notifications - Newser
Is scPharmaceuticals Inc. forming a reversal pattern2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Is scPharmaceuticals Inc. a candidate for recovery playJuly 2025 Summary & Comprehensive Market Scan Reports - Newser
What data driven models say about scPharmaceuticals Inc.’s futureEntry Point & Precise Buy Zone Identification - Newser
Is scPharmaceuticals Inc. stock bottoming outJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Momentum divergence signals in scPharmaceuticals Inc. chartMarket Volume Summary & Weekly Momentum Stock Picks - Newser
scPharmaceuticals Inc. Stock Performance After Earnings: Historical Insights2025 Market Sentiment & Smart Investment Allocation Tips - Newser
Building trade automation scripts for scPharmaceuticals Inc.Portfolio Risk Summary & Low Risk Entry Point Tips - Newser
scPharmaceuticals Inc. stock trendline breakdown2025 Fundamental Recap & Consistent Profit Alerts - Newser
Why scPharmaceuticals Inc. stock attracts strong analyst attentionJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Quantitative breakdown of scPharmaceuticals Inc. recent moveProduct Launch & Fast Momentum Entry Tips - Newser
scPharmaceuticals secures notice of allowances of multiple US patent applications covering SCP-111 - MSN
Can a trend reversal in scPharmaceuticals Inc. lead to recoveryEarnings Summary Report & AI Enhanced Trading Alerts - Newser
Sentiment analysis tools applied to scPharmaceuticals Inc.2025 Biggest Moves & Safe Swing Trade Setups - Newser
Published on: 2025-08-15 05:16:39 - sundaytimes.kr
Sector Update: Health Care - MarketScreener
ScPharmaceuticals Inc. shares rise 1.05% intraday after receiving five patent allowances for SCP-111 formulation. - AInvest
scPharmaceuticals receives five patent allowances for furosemide formulation By Investing.com - Investing.com Nigeria
scPharmaceuticals Strengthens IP Portfolio with 5 New Patents for Innovative Heart Failure Treatment - Stock Titan
SCPharmaceuticals to Meet with Craig-Hallum on August 19 - AInvest
What’s the recovery path for long term holders of scPharmaceuticals Inc.Daily Trade Setup Forecast with Confidence - Newser
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2025 Earnings Call Transcript - Insider Monkey
Does scPharmaceuticals Inc. qualify in momentum factor screeningAI Volatility Forecast and Risk Monitor - Newser
Strategies to average down on scPharmaceuticals Inc.Free Swing Setup With Technical Confirmation - Newser
Comparing scPharmaceuticals Inc. in custom built stock radarsFree Daily Smart Money Movement Monitor - Newser
Chart based analysis of scPharmaceuticals Inc. trendsLow Exposure Strategy with Sector Analysis - Newser
What earnings revisions data tells us about scPharmaceuticals Inc.Free Watchlist for Smart Swing Trading - Newser
How to monitor scPharmaceuticals Inc. with trend dashboardsEntry Optimization Guide with Volume Analysis - Newser
Using Bollinger Bands to evaluate scPharmaceuticals Inc.Real-Time Entry Forecast with Accuracy Metrics - Newser
Wall Street Zen Upgrades scPharmaceuticals (NASDAQ:SCPH) to “Hold” - Defense World
Analyzing scPharmaceuticals Inc. with multi timeframe chartsShort-Term AI-Based Stock Price Forecast - Newser
What Fibonacci levels say about scPharmaceuticals Inc. reboundVolume Confirmed Setup with Entry Confidence - Newser
How scPharmaceuticals Inc. stock performs during market volatility [Gold Moves]Long Hold Capital Preservation Plans - Newser
What institutional flow reveals about scPharmaceuticals Inc.Free Market Surge Signal for Swing Traders - Newser
Scpharmaceuticals Inc (SCPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):